Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay

Journal of Endotoxin Research

Volumn 12, Issue 3, 2006, Pages 171-180

  Dehus, Oliver ^a   Hartung, Thomas ^b   Hermann, Corinna ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

Bacteria; Cytokines; Human blood; LPS; Potency

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; PHENOL; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; BACTERIAL TOXIN; CYTOKINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ESCHERICHIA COLI; HUMAN; IMMUNOSTIMULATION; INTERMETHOD COMPARISON; LIMULUS LYSATE TEST; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS EQUI; ULTRAVIOLET RADIATION; VIBRIO CHOLERAE; ANIMAL; BLOOD; BONE MARROW CELL; C3H MOUSE; CLASSIFICATION; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; LEUKOCYTE; METABOLISM; METHODOLOGY; MOUSE MUTANT;

ENTEROBACTERIACEAE; LIMULUS; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL TOXINS; BLOOD; BONE MARROW CELLS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMANS; LEUKOCYTES; LIMULUS TEST; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; PSEUDOMONAS AERUGINOSA; TOLL-LIKE RECEPTORS;

EID: 33745963648     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805106X102156     Document Type: Article

References (56)

1. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992; 267: 54-61.
2. Vogel SN, Hogan MM The role of cytokines in endotoxin-mediated host responses. In: Oppenheimer JJ, Shevach (eds). Immunopharmacology. USA: Oxford University Press, 1990: 238-258.
3. Morrison DC, Ryan JL Endotoxins and disease mechanisms. Annu Rev Med 1987; 38: 417-432.
4. Raetz CR Biochemistry of endotoxins. Annu Rev Biochem 1990; 59: 129-170.
5. Raetz CR Bacterial lipopolysaccharides: A remarkable family of bioactive macroamphiphiles. In: Neidhart FC (ed). Escherichia coli and Salmonella: cellular and molecular biology. American Society for Microbiology, 1996: 48.
6. Rietschel ET, Kirikae T., Schade UF et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-225.
7. Rietschel ET, Brade H., Brade L. et al. Lipid A, the endotoxic center of bacterial lipopolysaccharides: Relation of chemical structure to biological activity. Prog Clin Biol Res 1987; 231: 25-53.
8. Rietschel ET, Wollenberg HW, Brade H. et al. Structure and function of the lipid A component of lipopolysaccharides. Handbook Endotoxins 1984; 1: 187-220.
9. Tanamoto K., Zahringer U., McKenzie GR et al. Biological activities of synthetic lipid A analogs: Pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun 1984; 44: 421-426.
10. Galanos C., Luderitz O., Rietschel ET et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 1985; 148: 1-5.
11. Loppnow H., Brade L., Brade H. et al. Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol 1986; 16: 1263-1267.
12. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
13. Watson J., Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med 1974; 140: 1147-1161.
14. Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
15. Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998; 188: 2091-2097.
16. Yang RB, Mark MR, Gray A. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288.
17. Hirschfeld M., Ma Y., Weis JH, Vogel SN, Weis JJ Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618-622.
18. Erridge C., Bennett-Guerrero E., Poxton IR Structure and function of lipopolysaccharides. Microbes Infect 2002; 4: 837-851.
19. Lorenz E., Patel DD, Hartung T., Schwartz DA Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect Immun 2002; 70: 4892-4896.
20. Werts C., Tapping RI, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2: 346-352.
21. Vogel S., Hirschfeld MJ, Perera PY Signal integration in lipopolysaccharide (LPS)-stimulated murine macrophages. J Endotoxin Res 2001; 7: 237-241.
22. Hirschfeld M., Weis JJ, Toshchakov V. et al. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001; 69: 1477-1482.
23. Caroff M., Karibian D., Cavaillon JM, Haeffner-Cavaillon N. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 2002; 4: 915-926.
24. Netea MG, van Deuren M., Kullberg BJ, Cavaillon JM, Van der Meer JW Does the shape of lipid A determine the interaction of LPS with Toll-like receptors ? Trends Immunol 2002; 23: 135-139.
25. Hartung T. Die Erfassung von Pyrogenen in einem humanen Vollblutmodell. Altex 1995: 70-75.
26. Morath S., Geyer A., Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 2001; 193: 393-397.
27. Hartung T., Docke WD, Gantner F. et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482-2489.
28. Zughaier SM, Ryley HC, Jackson SK Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 1999; 67: 1505-1507.
29. Mathiak G., Kabir K., Grass G. et al. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays. Int J Mol Med 2003; 11: 41-44.
30. Erridge C., Pridmore A., Eley A., Stewart J., Poxton IR Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J Med Microbiol 2004; 53: 735-740.
31. Broady KW, Rietschel ET, Luderitz O. The chemical structure of the lipid A component of lipopolysaccharides from Vibrio cholerae. Eur J Biochem 1981; 115: 463-468.
32. Takayama K., Qureshi N. Chemical structure of lipid A. Bacterial Endotoxic Lipopolysaccharides 1992; 1: 43-60.
33. Loppnow H., Libby P., Freudenberg M., Krauss JH, Weckesser J., Mayer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun 1990; 58: 3743-3750.
34. Qureshi N., Takayama K., Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991; 59: 441-444.
35. Golenbock DT, Hampton RY, Qureshi N., Takayama K., Raetz CR Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.
36. Schromm AB, Brandenburg K., Loppnow H. et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000; 267: 2008-2013.
37. Soong G., Reddy B., Sokol S., Adamo R., Prince A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 2004; 113: 1482-1489.
38. Adamo R., Sokol S., Soong G., Gomez MI, Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and Toll-like receptor 2 as well as Toll-like receptor 5. Am J Respir Cell Mol Biol 2004; 30: 627-634.
39. Sadikot RT, Zeng H., Yull FE et al. p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol 2004; 172: 1801-1808.
40. Faure K., Sawa T., Ajayi T. et al. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir Res 2004; 5: 1.
41. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002; 3: 354-359.
42. Green SK, Schroth MN, Cho JJ, Kominos SK, Vitanza-Jack VB Agricultural plants and soil as a reservoir for Pseudomonas aeruginosa. Appl Microbiol 1974; 28: 987-991.
43. Williams PA, Worsey MJ Ubiquity of plasmids in coding for toluene and xylene metabolism in soil bacteria: Evidence for the existence of new TOL plasmids. J Bacteriol 1976; 125: 818-828.
44. Cappelli G., Tetta C., Cornia F. et al. Removal of Limulus reactivity and cytokine-inducing capacity from bicarbonate dialysis fluids by ultrafiltration. Nephrol Dial Transplant 1993; 8: 1133-1139.
45. Sundaram S., Barrett TW, Meyer KB et al. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers. J Am Soc Nephrol 1996; 7: 2183-2191.
46. Lyczak JB, Cannon CL, Pier GB Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes Infect 2000; 2: 1051-1060.
47. Ohman DE, Burns RP, Iglewski BH Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis 1980; 142: 547-555.
48. Woods DE, Cryz Jr SJ, Friedman RL, Iglewski BH Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 1982; 36: 1223-1228.
49. Buret A., Cripps AW The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis 1993; 148: 793-805.
50. Cripps AW, Dunkley ML, Clancy RL, Kyd J. Pulmonary immunity to Pseudomonas aeruginosa. Immunol Cell Biol 1995; 73: 418-424.
51. Lin TJ, Garduno R., Boudreau RT, Issekutz AC Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J Immunol 2002; 169: 4522-4530.
52. Franzetti F., Cernuschi M., Esposito R., Moroni M. Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 1992; 231: 437-443.
53. Kielhofner M., Atmar RL, Hamill RJ, Musher DM Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis 1992; 14: 403-411.
54. Giamarellos-Bourboulis EJ, Plachouras D., Tzivra A. et al. Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: An in vitro and in vivo study. Clin Exp Immunol 2004; 135: 240-246.
55. Tanamoto K., Homma JY Essential regions of the lipopolysaccharide of Pseudomonas aeruginosa responsible for pyrogenicity and activation of the proclotting enzyme of horseshoe crabs. Comparison with antitumor, interferon-inducing and adjuvant activities. J Biochem (Tokyo) 1982; 91: 741-746.
56. Laude-Sharp M., Haeffner-Cavaillon N., Caroff M., Lantreibecq F., Pusineri C., Kazatchkine MD Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from Gram-negative bacteria. Cytokine 1990; 2: 253-258.